medication and insulin Flashcards
medication: will cause weight gain
insulin secretagogues ( especially, glyburide), TZD
medication: may increase the risk of hypotension
insulin secretagogues
medication: DKA
contraindication: AGIs
medication: CVD protection
insulin secretagogues
SGLT2- inhibitors (decrease A1C, BP. weight decrease)
medication: good monotherapy (low/negligible safety risk)
AGIs, TZDs,SGLT2- inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors
insulin secretagoguesL specific benefit (1)
rapid onset of response, PG BG reduced bu meglitinides
AGIs: specific benefit and risk (1+1)
prevention T2DM in pts with IGT
not recommended as initial Thx in ppl A1C% >/= 8.5%
medication: concern longterm safety
SGLT2- inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors
medication: contraindicate to liver problem
iazolidinediones (TZDs)
medication: CVD risk
DPP-4 inhibitors (cardiac insufficiency)